Zeltia facts for kids
 |
|
| Sociedad Anónima | |
| Traded as | BMAD: ZEL |
| ISIN | ISIN: [https://isin.toolforge.org/?language=en&isin=ES0184940817 ES0184940817] |
| Industry | Pharmaceutical |
| Founded | Vigo, Galicia, Spain (August 3, 1939) |
| Defunct | 2015 |
| Headquarters |
Madrid
,
Spain
|
|
Area served
|
Worldwide |
|
Key people
|
José Fernández Sousa-Faro (Chairman) |
| Products | Pharmaceuticals |
| Revenue |  US$176 million (2009) |
|
Operating income
|
(US$46.3) million (2009) |
| (US$40.3) million (2009) |
|
| Total assets | US$302.9 million (2009) |
| Total equity |  US$59 million (2009) |
| Subsidiaries | PharmaMar, Genómica, Sylentis, Zelnova, Xylazel |
Zeltia was a Spanish company that made medicines and chemicals. It worked through many smaller companies called subsidiaries. These subsidiaries focused on different areas in the health and chemical industries.
By 2007, Zeltia's research into new medicines had not yet created a product to sell. The main owner and the chairman of the company were the same person. This meant there was less pressure to make money very quickly.
Contents
History of Zeltia
Zeltia was founded in 1939 in Vigo, Spain. It grew to become an important company in its field.
Key Events in Zeltia's History
In 1993, Zeltia sold one of its smaller companies, Cooper-Zeltia. This company later changed its name to Zendal.
Later, Zeltia itself was taken over by one of its own subsidiaries, Pharma Mar. This was a special kind of takeover called a "reverse takeover." Even after this, the main structure of the Zeltia Group stayed the same.
In 2018, PharmaMar sold Xylazel. Xylazel was another company that belonged to the group. It was sold to a Dutch company called AkzoNobel.
In 2019, PharmaMar sold Zelnova. Zelnova was the last company in the group that was still located in Galicia, Spain. It was sold to a Spanish investment company for 33 million euros.
Zeltia's Subsidiaries
A subsidiary is a company that is owned or controlled by another larger company. Zeltia had several direct and indirect subsidiaries.
Direct Subsidiaries of Zeltia (2009)
As of 2009, these companies were directly owned by Zeltia:
- Pharma Mar, S.A.U.
- Genómica, S.A.U.
- Zelnova, S.A.
- Protección de Maderas, S.A.U.
- Xylazel, S.A.
- Noscira, S.A.
- Sylentis, S.A.
Indirect Subsidiaries of Zeltia (2009)
Some companies were owned by Pharma Mar, which was itself a direct subsidiary of Zeltia. These were called indirect subsidiaries:
- Pharma Mar US
- Pharma Mar AG
- PharmaMar S.A.R.L.
- Pharma Mar GmbH
- Pharma Mar Ltd.
There was also one indirect subsidiary that was directly owned by Zelnova:
- Copyr, S.p.A.
